发明名称 Análogos nucleosídicos con base monocíclica de carboxamidina modificada
摘要 <p>The inventions relates to the use of the carboxamidine of Formula 1, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of a Hepatitis C Virus (HCV) viral infection or a Hepatitis B Virus (HBV) viral infection, wherein the compound is in L-configuration or D-configuration.</p>
申请公布号 ES2528429(T3) 申请公布日期 2015.02.09
申请号 ES20070107588T 申请日期 2001.02.15
申请人 VALEANT PHARMACEUTICALS NORTH AMERICA 发明人 TAM, ROBERT;RAMASAMY, KANDA;HONG, ZHI;LAU, JOHNSON
分类号 A61K31/70;A01P17/00;A61K31/7052;A61K31/7056;A61K31/7068;A61K38/21;A61P1/16;A61P3/10;A61P17/00;A61P19/02;A61P25/00;A61P25/28;A61P29/00;A61P31/12;A61P31/18;A61P33/00;A61P35/00;A61P37/02;C07H19/056;C07H19/14 主分类号 A61K31/70
代理机构 代理人
主权项
地址